Editorial
Published on 21 Mar 2022
Editorial: The Elephant in the Room: AML Relapse After Allogeneic Hematopoietic Cell Transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.863800
- 1,679 views
Type at least 3 characters
2,064 articles
articles
Case Report
Published on 21 Mar 2022
Case Report: Outcome and Adverse Events of Anti-PD-1 Antibody Plus Chidamide for Relapsed/Refractory Sézary Syndrome: Case Series and A Literature Review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.842123
- 3,692 views
- 4 citations
Original Research
Published on 18 Mar 2022
Impact of IDH1 c.315C>T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.804961
- 4,017 views
- 5 citations
Brief Research Report
Published on 17 Mar 2022
Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.826040
- 4,913 views
- 10 citations
Original Research
Published on 17 Mar 2022
Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.805702
- 4,156 views
- 8 citations
Original Research
Published on 17 Mar 2022
Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.772015
- 3,067 views
- 9 citations
Original Research
Published on 16 Mar 2022
Acute Myeloid Leukemia Cells Functionally Compromise Hematopoietic Stem/Progenitor Cells Inhibiting Normal Hematopoiesis Through the Release of Extracellular Vesicles
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.824562
- 9,911 views
- 17 citations
Original Research
Published on 16 Mar 2022
Decitabine-Intensified Modified Busulfan/Cyclophosphamide Conditioning Regimen Improves Survival in Acute Myeloid Leukemia Patients Undergoing Related Donor Hematopoietic Stem Cell Transplantation: A Propensity Score Matched Analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.844937
- 3,878 views
- 17 citations
Systematic Review
Published on 16 Mar 2022
The Coming of Age of Preclinical Models of MDS
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.815037
- 7,624 views
- 19 citations
Brief Research Report
Published on 14 Mar 2022
Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.851864
- 5,207 views
- 15 citations
Original Research
Published on 11 Mar 2022
Efficacy of Intermittent, Oral Famciclovir Prophylaxis for Bortezomib-Induced Herpes Zoster in Multiple Myeloma Patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.843032
- 4,751 views
- 6 citations
Original Research
Published on 10 Mar 2022
Identification of a Mitochondria-Related Gene Signature to Predict the Prognosis in AML
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.823831
- 8,934 views
- 18 citations
Original Research
Published on 10 Mar 2022
Methylation of SPRED1: A New Target in Acute Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.854192
- 3,601 views
- 4 citations
Original Research
Published on 10 Mar 2022
Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.840616
- 19,603 views
- 66 citations
Review
Published on 10 Mar 2022
Cytokines in the Pathogenesis of Large Granular Lymphocytic Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.849917
- 5,490 views
- 17 citations
Editorial
Published on 10 Mar 2022
Editorial: Molecular Mechanisms of Multiple Myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.870123
- 2,938 views
- 1 citation
Mini Review
Published on 09 Mar 2022
Mature T-Cell leukemias: Challenges in Diagnosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.777066
- 9,327 views
- 9 citations
Mini Review
Published on 09 Mar 2022
Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.830922
- 7,523 views
- 18 citations
Review
Published on 09 Mar 2022
Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.813149
- 9,180 views
- 26 citations
Review
Published on 09 Mar 2022
Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.787108
- 11,293 views
- 20 citations
Case Report
Published on 08 Mar 2022
Case Report: Free-Floating Intracoronary Thrombus: Who Is the Convict?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.825711
- 1,821 views
- 1 citation
Original Research
Published on 07 Mar 2022
Management of Chronic Myeloid Leukemia and Pregnancy: A Bibliometric Analysis (2000-2020)
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.826703
- 9,372 views
- 17 citations
Editorial
Published on 07 Mar 2022
Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.872300
- 1,686 views
- 1 citation
Case Report
Published on 04 Mar 2022
Acute Promyelocytic Leukemia Presenting With a Myeloid Sarcoma of the Spine: A Case Report and Literature Review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.851406
- 4,330 views
- 10 citations